EULAR Non-Pharmacological Core Management of Hip and Knee Osteoarthritis Guideline Summary - Guideline Central
Overarching Principles
Summary of Recommendations
Document Overview

Non-Pharmacological Core Management of Hip and Knee Osteoarthritis

European League Against Rheumatism (EULAR)


Publication Date: May 15, 2024

Page Last Updated: May 6, 2026

Recommendation Grading

LOEMeaning
1asystematic review of RCTs
1bindividual RCT
2asystematic review of cohort studies
2bindividual cohort study (and low-quality RCT)
3asystematic review of case–control studies
3bindividual case–control study
4case series and poor-quality cohort and case–control studies
5expert opinion without explicit critical appraisal, or based on physiology, bench research or ‘first principles’
 
SORMeaning
Aconsistent level 1 studies
Bconsistent level 2 or 3 studies, or extrapolations from level 1 studies
Clevel 4 studies or extrapolations from level 2 or 3 studies
Dlevel 5 evidence or troublingly inconsistent or inconclusive studies of any level

Document Overview

Document Title
Non-Pharmacological Core Management of Hip and Knee Osteoarthritis
Authoring Society

European League Against Rheumatism (EULAR)

Document Publication Date
May 15, 2024
Page Last Reviewed/Updated
May 6, 2026
Document Type
Consensus Statement
Country of Publication
European
Full Text Freely Available
Yes
Full Text Guideline
ard.bmj.com/content/83/6/730
Source Citation

Moseng T, Vliet Vlieland TPM, Battista S, Beckwée D, Boyadzhieva V, Conaghan PG, Costa D, Doherty M, Finney AG, Georgiev T, Gobbo M, Kennedy N, Kjeken I, Kroon FPB, Lohmander LS, Lund H, Mallen CD, Pavelka K, Pitsillidou IA, Rayman MP, Tveter AT, Vriezekolk JE, Wiek D, Zanoli G, Østerås N. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update. Ann Rheum Dis. 2024 May 15;83(6):730-740. doi: 10.1136/ard-2023-225041. PMID: 38212040; PMCID: PMC11103326.

Document Scope, Criteria, and Use Cases

Document Objectives

Update the 2013 evidence-based recommendations for non-pharmacological core management, provide additional details on effectiveness, safety and cost-effectiveness, and formulate research and educational agendas and priorities for implementation activities.

Scope
Management, Rehabilitation, Treatment
Diseases/Conditions (MeSH)

D020370 - Osteoarthritis, Knee

D020370 - Osteoarthritis, Knee

Keywords
Hip and knee osteoarthritis, osteoarthritis
Target Patient Population
Patients with hip and knee osteoarthritis
Target Provider Population
Orthopedic surgeons, rheumatologists, physical therapists, pain management specialists, rehabilitation specialists, primary care physicians, radiologists, sports medicine specialists
Inclusion Criteria
Male, Female, Adult, Older Adult
Health Care Settings
Ambulatory, Operating and Recovery Room
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.